Panbela Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Panbela Therapeutics

13/05/2021 01:31

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted loss of 23 cents​​ per share for the quarter ended
in March. The mean expectation of two analysts for the quarter
was for a loss of 11 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Panbela Therapeutics Inc's reported EPS for the quarter was a
loss of 23 cents​.
* The mean earnings estimate of analysts had risen by
about 26.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Panbela Therapeutics Inc shares had risen by 5.3% this
quarter and gained 16.9% so far this year.
* The company reported a quarterly loss of $2.26 million.
* Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $8.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 13 at 12:31 a.m. GMT.
​All figures in US dollars